ImpediMed Limited (ASX:IPD) Announces Q3 Revenue and ARR Growth
ImpediMed Limited (ASX:IPD) reports record Q3 revenue and ARR growth, along with key operational and management developments.
ImpediMed Limited (ASX:IPD) reports record Q3 revenue and ARR growth, along with key operational and management developments.
Wisr (ASX:WZR) upgrades FY25 loan origination growth guidance to over 90%, reporting strong Q3FY25 financial performance and improved loan book quality.
Appen Limited (ASX:APX) reports Q1 FY25 revenue of $50.2M, improved EBITDA loss, and a strong cash position.
Sparc Technologies Limited (ASX: SPN) releases its March 2025 Quarterly Report, highlighting advancements in green hydrogen and graphene-based additives alongside key corporate and financial updates.
Ionic Rare Earths (ASX: IXR) reports significant progress in magnet recycling and heavy rare earth projects, reducing CO₂ emissions.
EOS (ASX:EOS) announces significant business restructuring, portfolio divestments, and financial repayments as part of its ongoing turnaround strategy.
Mesoblast Limited (ASX:MSB) reports Q1 2025 milestones, including the US launch of Ryoncil® and strong financial performance.
Aurora Labs (ASX:A3D) completes development of the AU4 micro gas turbine, advancing production and defence sector engagements.
4DS Memory (ASX:4DS) reports Q1 2025 progress, including technical advancements and increased cash reserves.
NOVONIX Limited (ASX:NVX) finalizes a $5 million land purchase in Chattanooga, expanding production capacity and creating up to 500 jobs.